“…In addition, the Anxiety (AXY) scale has been identified as a key indicator of PTSD symptomatology (e.g., Arbisi et al, 2011;Sellbom et al, 2012). Beyond use as an aid for assessing PTSD, the MMPI-2-RF substantive scales also predict a variety of clinically relevant criteria across other VA treatment settings, including substance use treatment programs (Forbey & Ben-Porath, 2007), inpatient and outpatient mental health settings (Nelson, Anderson, Hoelzle, & Arbisi, 2014), and primary care (Forbey, Ben-Porath, & Arbisi, 2012;Ingram et al, 2019a).…”